The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.

| Build smarter healthcare apps, faster. See how clinical data repositories help developers unlock clinical data and drive ...

Greenway Health and Moxe Health have partnered to automate the exchange of clinical data for ambulatory practices. The ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, ...

Cabaletta Bio ( ($CABA) ) has issued an update. On October 27, 2025, Cabaletta Bio announced positive clinical data and development updates from ...

Because the data [are] contextualized, we know who the physicians are [that are] working with the patients we aspire to treat ...

BOOST Pharma, a clinical-stage cell biotech company focused on rare skeletal pediatric diseases, is proud to announce that new long-term data from the first-in-class BOOSTB4 stem cell therapy trial ...

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year ...

Somatostatin analogs (SSAs) like octreotide LAR and lanreotide are essential in managing NETs. Standard practice involves ...

Thermo Fisher Scientific has agreed to acquire Clario Holdings for nearly $8.9 billion, in a deal that would give it control of a widely used digital toolkit for managing clinical trial data.

A new tool at its Tisch Cancer Center helps improve accuracy, efficiency and patient access by streamlining information from the Epic EHR to clinical trial platforms.